Antibodies to Fas-L for treatment of hepatitis
US6068841A · kind A · utility
1Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 1998 |
| Grant date | May 30, 2000 |
| Priority date | — |
| Expiry date | Apr 27, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides therapeutic agents for hepatitis, comprising an antibody against a human Fas ligand, or an active fragment thereof as an active ingredient. The therapeutic agents for hepatitis according to the invention are particularly effective for the treatment of hepatitis caused by the death of hepatocytes due to apoptosis among many kinds of hepatitis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.